Edgewise Therapeutics SG&A Expense (Annual) Analysis

Edgewise Therapeutics Inc (EWTX)

26.09 +0.10 (+0.38%) USD | NASDAQ | Sep 27, 16:00

26.06 -0.03 (-0.11%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	23.45M
December 31, 2022	17.63M
December 31, 2021	11.03M

Date	Value
December 31, 2020	2.209M
December 31, 2019	1.30M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

1.30M

Minimum

2019

23.45M

Maximum

2023

11.12M

Average

11.03M

Median

2021

SG&A Expense (Annual) Benchmarks